Geneos Wealth Management Inc. lifted its stake in Oracle Co. (NYSE:ORCL – Free Report) by 3.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,352 shares of the enterprise software provider’s stock after purchasing an additional 765 shares during the period. Geneos Wealth Management Inc.’s holdings in Oracle were worth $3,558,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Aspiring Ventures LLC acquired a new position in shares of Oracle during the 4th quarter worth approximately $284,000. Fifth Third Bancorp boosted its stake in Oracle by 0.3% in the 4th quarter. Fifth Third Bancorp now owns 1,174,621 shares of the enterprise software provider’s stock valued at $195,739,000 after purchasing an additional 3,788 shares during the period. DGS Capital Management LLC increased its position in Oracle by 2.7% during the fourth quarter. DGS Capital Management LLC now owns 6,659 shares of the enterprise software provider’s stock worth $1,110,000 after acquiring an additional 173 shares during the period. Goelzer Investment Management Inc. grew its position in Oracle by 10.4% during the fourth quarter. Goelzer Investment Management Inc. now owns 6,838 shares of the enterprise software provider’s stock worth $1,139,000 after buying an additional 646 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. increased its position in shares of Oracle by 6,613.2% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 149,974 shares of the enterprise software provider’s stock worth $24,992,000 after purchasing an additional 147,740 shares during the period. 42.44% of the stock is owned by institutional investors.
Oracle Stock Down 1.5 %
Shares of NYSE:ORCL opened at $183.59 on Friday. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. The firm’s 50 day moving average price is $174.41 and its 200 day moving average price is $162.49. The stock has a market cap of $513.50 billion, a price-to-earnings ratio of 44.89, a price-to-earnings-growth ratio of 3.62 and a beta of 1.06. Oracle Co. has a fifty-two week low of $106.51 and a fifty-two week high of $198.31.
Oracle Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, January 9th. Investors of record on Thursday, January 23rd were given a $0.40 dividend. The ex-dividend date of this dividend was Friday, January 10th. This represents a $1.60 annualized dividend and a dividend yield of 0.87%. Oracle’s dividend payout ratio is presently 39.12%.
Analyst Ratings Changes
A number of equities analysts recently issued reports on ORCL shares. Evercore ISI upped their price objective on shares of Oracle from $190.00 to $200.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. KeyCorp increased their target price on shares of Oracle from $190.00 to $200.00 and gave the company an “overweight” rating in a report on Friday, November 15th. Royal Bank of Canada reissued a “sector perform” rating and set a $165.00 target price on shares of Oracle in a research report on Thursday, December 5th. JMP Securities restated a “market outperform” rating and set a $205.00 target price on shares of Oracle in a research report on Wednesday. Finally, Mizuho boosted their price objective on Oracle from $185.00 to $210.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $182.73.
Read Our Latest Stock Analysis on Oracle
Insider Transactions at Oracle
In other Oracle news, CEO Safra Catz sold 2,101,154 shares of the firm’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $185.35, for a total transaction of $389,448,893.90. Following the completion of the sale, the chief executive officer now owns 1,118,592 shares in the company, valued at $207,331,027.20. This trade represents a 65.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 42.20% of the company’s stock.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories
- Five stocks we like better than Oracle
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Bloom Energy: Powering the Future With Decentralized Energy
- Stock Market Upgrades: What Are They?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Quiet Period Expirations Explained
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.